Morelli Law

Your SUPER-powered WP Engine Site

Morelli Law Firm Operations Continue Remotely and Uninterrupted
Morelli Law Firm
  • About
    • Traumatic Brain Injury (TBI) Survivor Scholarship
  • Our Attorneys
  • Results
  • Practice Areas
    • Truck & Auto Accidents Lawyers
    • Construction Accidents Lawyers
    • Defective Drugs/Devices Lawyers
    • Employment Discrimination Lawyers
    • Medical Malpractice Lawyers
    • Personal Injury Lawyers
    • Railroad/FELA Lawyers
    • Sexual Harassment Lawyers
  • RESOURCES
    • FAQ
    • Press
    • Blog
    • Broadcast
  • Testimonials
  • Areas We Serve

Toll Free877-751-9800

Request Case Evaluation

x
  • Morelli Law Firm
  • Request Case Evaluation
  • About
    • Traumatic Brain Injury (TBI) Survivor Scholarship
  • Our Attorneys
  • Results
  • Practice Areas
    • Truck & Auto Accidents Lawyers
    • Construction Accidents Lawyers
    • Defective Drugs/Devices Lawyers
    • Employment Discrimination Lawyers
    • Medical Malpractice Lawyers
    • Personal Injury Lawyers
    • Railroad/FELA Lawyers
    • Sexual Harassment Lawyers
  • RESOURCES
    • FAQ
    • Press
    • Blog
    • Broadcast
  • Testimonials
  • Areas We Serve
Home » Blog » Class Actions » Lawsuit Highlights Role Of Generic Drug Makers In Updating Safety Labeling
Lawsuit Highlights Role Of Generic Drug Makers In Updating Safety Labeling
  • Share this page

How fast does a generic drug maker have to update its product labeling to match changes to the equivalent brand-name medication? The question has arisen during a lawsuit by a California woman who suffered a fracture while using a generic version of osteoporosis medication Fosamax.

It is alleged that although Fosamax updated its labeling to include newly discovered side effects of the drug, namely the risk of a femur fracture, the makers of the generic medication she had been prescribed had not updated these new risk factors in a timely manner.

According to court documents, the generic labels were updated six weeks after the brand-name version had changed its labels to include the new risk information, and that delay caused the woman to suffer harm. The requisite timeliness of updating such warnings has become a central issue in the case, which the Supreme Court has been asked to review.

Request A Case Evaluation

    To Top
    Morelli Law Firm

    New York: 212-751-9800

    Toll Free: 877-751-9800

    New York: 212-751-9800

    Toll Free: 877-751-9800

    Stay Connected

    • Terms of Use
    • Privacy Policy
    • Site Map
    © 2021 Morelli Law, All rights reserved.